ImpriMed offers personalized medicine for pets with blood cancer, providing a Chemo Response Prediction Service used by veterinary oncologists. Over 2,000 dogs with lymphoma and leukemia have been helped. The service allows veterinarians to make treatment decisions quickly and confidently. The company's innovative approach has been published and presented at major conferences, and is supported by over 150 veterinary oncologists at specialty hospitals in the US.